SCHEMBL3759468

SCHEMBL3759468

O=[N+]([O-])c1ccc(-c2ccc(/C=N/c3ccccc3O)o2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 17/20 0.71
▸ KMT2A Q03164 14/20 0.71
▸ MEN1 O00255 13/20 0.71
▸ ALDH1A1 P00352 4/20 0.71
▸ KDM4E B2RXH2 3/20 0.71
▸ HPGD P15428 1/20 0.71
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ TNNI3 P19429 1/20 0.58
▸ TNNT2 P45379 1/20 0.58
▸ TNNC1 P63316 1/20 0.58
▸ HTT P42858 1/20 0.56
▸ POLB P06746 1/20 0.53
▸ HTR1E P28566 1/20 0.53
▸ S1PR3 Q99500 1/20 0.53
▸ ABCB11 O95342 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ ADORA1 P30542 1/20 0.52
▸ CISD1 Q9NZ45 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3682237 1.00 MAPT (0.71) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL3684656 0.88 MAPT (0.66) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL3763988 0.88 MAPT (0.66) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL3681296 0.87 MAPT (0.65) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL3762518 0.87 MAPT (0.65) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL3768960 0.81 MAPT (0.53) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL3681086 0.81 MAPT (0.53) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL12443115 0.80 CDK2 (0.58) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL6825490 0.80 CDK2 (0.58) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL27424077 0.79 LMNA (0.58) MAPTKMT2AMEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426540-B2 Tridentate ligand compounds with imino furan units, method for manufacturing said compounds, and their use in the preparation of catalysts for the homopolymerisation and copolymerisation of ethylene and alpha-olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2013-04-23 — — US claimed
US-20100311930-A1 New Tridentate Ligand Compounds with Imino Furan Units, Method for Manufacturing Said Compounds, and their use in the Preparation of Catalysts for the Homopolymerisation and Copolymerisation of Ethylene and Alpha-Olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-12-09 — — US claimed
EP-2003125-A1 NEW TRIDENTATE LIGAND COMPOUNDS WITH IMINO FURAN UNITS, METHOD FOR MANUFACTURING SAID COMPOUNDS, AND THEIR USE IN THE PREPARATION OF CATALYSTS FOR THE HOMOPOLYMERISATION AND COPOLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2008-12-17 — — EP claimed
US-8426540-B2 Tridentate ligand compounds with imino furan units, method for manufacturing said compounds, and their use in the preparation of catalysts for the homopolymerisation and copolymerisation of ethylene and alpha-olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2013-04-23 — — US disclosed
US-20100311930-A1 New Tridentate Ligand Compounds with Imino Furan Units, Method for Manufacturing Said Compounds, and their use in the Preparation of Catalysts for the Homopolymerisation and Copolymerisation of Ethylene and Alpha-Olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-12-09 — — US disclosed
EP-2003125-A1 NEW TRIDENTATE LIGAND COMPOUNDS WITH IMINO FURAN UNITS, METHOD FOR MANUFACTURING SAID COMPOUNDS, AND THEIR USE IN THE PREPARATION OF CATALYSTS FOR THE HOMOPOLYMERISATION AND COPOLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2008-12-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311930-A1 New Tridentate Ligand Compounds with Imino Furan Units, Method for Manufacturing Said Compounds, and their use in the Preparation of Catalysts for the Homopolymerisation and Copolymerisation of Ethylene and Alpha-Olefins FDFT1, ETFB, ETFA MAPT 1984/4885KMT2A 4413/4885MEN1 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback